← Eichor
Study identifier: NCT07022925 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

Condition: Perimenopause · Perimenopausal Depression · Perimenopausal Insomnia  ·  Sponsor: IdentifyHer Limited

PhaseN/A
Planned participants110
Who can joinFemale, 35 Years to 55 Years
Healthy volunteersNo

About this study

The goal of this observational study is to investigate the accuracy of the device in characterizing perimenopausal and menopausal symptoms including vasomotor symptoms, anxiety, sleep quality compared to self-reported symptoms via an app. The main question it aims to answer is: What is the accuracy of the developed algorithm from the investigational device compared to daily self-report via an app in characterizing perimenopausal symptoms? Participants will be asked to wear IndentifyHer's wearable non-invasive sensor and complete a daily electronic diary and questionnaires on stress, anxiety, and sleep.

This description comes directly from the study's public registry record.

Talk to the study team

Marc Moulin, PhD  ·  +12267819094;ext=300  ·  mmoulin@kgkscience.com

Always discuss trial participation with your own doctor first.

Locations (1)

KGK Science Inc.London, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07022925